Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status

Author(s): Karina Petit and Jean-Francois Biard

Volume 13, Issue 4, 2013

Page: [603 - 631] Pages: 29

DOI: 10.2174/1871520611313040010

Price: $65

Abstract

Marine ecosystems constitute a huge reservoir of biologically active secondary metabolites. Consequently during the last past few decades, several marine-derived molecules have been approved for anticancer treatment or are under clinical trials. This review reports the present state of the art of the sixteen molecules approved or currently on the clinical pipeline for anticancer chemotherapy. The molecules are classified according to their current status in the phase (approved / phase IV / phase III / phase II / phase I) and data are updated to April 2012.

Keywords: Brentuximab vedotin, Clinical trials, Cytarabine, Elisidepsin, Eribulin, ILX-651, KLH, Marine natural products, MMAE, MMAF, Plinabulin, plitidepsin, PM00104, PM01183, PM060184, Salinosporamide A, Trabectedin, TZT-1027


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy